Hawkins Capital’s Novartis NVS Stock Holding History

Hawkins Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.1M	Sell	27,900 -72,540	-72%	-$5.47M	3.79%	14
2017 Q3	$7.73M	Sell	100,440 -11,160	-10%	-$843K	3.2%	15
2017 Q2	$8.35M	Hold	111,600	–	–	2.89%	15
2017 Q1	$7.43M	Hold	111,600	–	–	2.37%	21
2016 Q4	$7.28M	Hold	111,600	–	–	2.33%	20
2016 Q3	$7.89M	Sell	111,600 -5,580	-5%	-$407K	2.53%	17
2016 Q2	$8.66M	Hold	117,180	–	–	2.89%	16
2016 Q1	$7.61M	Hold	117,180	–	–	2.9%	16
2015 Q4	$9.03M	Buy	+117,180	New	+$9.31M	3.55%	13
2015 Q3	–	Sell	-6,696	Closed	-$590K	–	19
2015 Q2	$590K	Sell	6,696 -11,160	-63%	-$1.02M	0.21%	18
2015 Q1	$1.58M	Hold	17,856	–	–	0.37%	14
2014 Q4	$1.48M	Hold	17,856	–	–	0.23%	16
2014 Q3	$1.51M	Hold	17,856	–	–	0.19%	18
2014 Q2	$1.45M	Hold	17,856	–	–	0.19%	17
2014 Q1	$1.36M	Hold	17,856	–	–	0.19%	17
2013 Q4	$1.29M	Hold	17,856	–	–	0.17%	17
2013 Q3	$1.23M	Hold	17,856	–	–	0.16%	20
2013 Q2	$1.13M	Buy	+17,856	New	+$1.16M	0.13%	22

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hawkins Capital's NVS Position: Q4 2017 in Review

Hawkins Capital reduced its Novartis (NVS) stake by 72% in Q4 2017, selling an estimated $5.47M and leaving 27,900 shares worth $2.1M. The position accounts for 3.79% of the portfolio, ranked #14.

Hawkins Capital first reported a position in NVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $9.03M in Q4 2015. 1,006 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

Hawkins Capital held 27,900 shares of Novartis worth $2.1M as of Q4 2017.
Hawkins Capital sold 72,540 Novartis shares in Q4 2017, an estimated $5.47M.
Novartis made up 3.79% of Hawkins Capital's portfolio in Q4 2017, its #14 holding.
Hawkins Capital first reported a position in Novartis in Q2 2013 and has held it in 18 quarters since.
Hawkins Capital's Novartis position peaked at $9.03M in Q4 2015.
1,006 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Hawkins Capital's 13F filing for Q4 2017, filed 12 Feb 2018.